Xenon Pharmaceuticals Inc. (XENE)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 03:22PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.02B |
| Enterprise Value | 2.39B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.25 |
| Enterprise Value/Revenue | 10.87k |
| Enterprise Value/EBITDA | -11.36 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.18 |
| 52-Week Change 3 | 0.60% |
| S&P500 52-Week Change 3 | 23.06% |
| 52 Week High 3 | 50.99 |
| 52 Week Low 3 | 27.99 |
| 50-Day Moving Average 3 | 44.76 |
| 200-Day Moving Average 3 | 39.69 |
Share Statistics
| Avg Vol (3 month) 3 | 363.35k |
| Avg Vol (10 day) 3 | 343.03k |
| Shares Outstanding 5 | 75.43M |
| Implied Shares Outstanding 6 | 75.43M |
| Float 8 | 69.56M |
| % Held by Insiders 1 | 0.38% |
| % Held by Institutions 1 | 99.99% |
| Shares Short (Mar 28, 2024) 4 | 2.76M |
| Short Ratio (Mar 28, 2024) 4 | 7.24 |
| Short % of Float (Mar 28, 2024) 4 | 3.67% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 3.65% |
| Shares Short (prior month Feb 29, 2024) 4 | 2.7M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -15.57% |
| Return on Equity (ttm) | -22.12% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -210.51M |
| Net Income Avi to Common (ttm) | -182.39M |
| Diluted EPS (ttm) | -2.73 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 638.08M |
| Total Cash Per Share (mrq) | 8.46 |
| Total Debt (mrq) | 10.9M |
| Total Debt/Equity (mrq) | 1.17% |
| Current Ratio (mrq) | 23.65 |
| Book Value Per Share (mrq) | 12.31 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -145.33M |
| Levered Free Cash Flow (ttm) | -98.4M |
© 2024 Yahoo. All rights reserved.